Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 47Breast Neoplasms 34Breast Neoplasms, Male 3Neoplasms 2Neoplasm Metastasis 2Infertility 2Advanced Breast Cancer 2Sexual Dysfunction, Physiological 1Recurrence 1Prostate Adenocarcinoma 1Primary Ovarian Insufficiency 1Osteoporosis 1Osteitis Deformans 1Leiomyoma 1Hot Flashes 1Hemorrhage 1Breast Cancer Invasive 1Anemia 1Advanced Prostate Cancer 1Advanced Metastatic Breast Cancer 1

Interventions

Leuprolide 1Goserelin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Advanced Prostate Cancer × Goserelin × Clear all
NCT03936218 2025-04-17

Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

Eurofarma Laboratorios S.A.

Phase 3 Completed
94 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡